Results 271 to 280 of about 81,608 (302)

Malignant peritoneal mesothelioma

Current Treatment Options in Oncology, 2001
This paper summarizes the author's thoughts about the use of cytoreductive surgery combined with intraperitoneal hyperthermic chemotherapy (CS-IPHC) for treatment of peritoneal malignant mesothelioma. Pleural malignant mesotheliomas are by far more common (about ten- to thirty-fold) than the peritoneal variants (2.2 cases per 1 million in the US ...
openaire   +2 more sources

Malignant Pleural Mesothelioma

Current Oncology Reports, 2011
Malignant pleural mesothelioma (MPM) is a relatively rare thoracic malignancy accounting for about 2000-3000 new cases per year. This cancer has been increasing in incidence and is strongly associated with asbestos exposure. Also, it is characterized by insidious growth and clinical presentation at an advanced stage of disease.
Siva, Raja, Sudish C, Murthy, David P, Mason   +2 more
openaire   +2 more sources

Localized Malignant Mesothelioma

American Journal of Surgical Pathology, 2005
Localized malignant mesotheliomas are uncommon sharply circumscribed tumors of the serosal membranes with the microscopic appearance of diffuse malignant mesothelioma but without any evidence of diffuse spread. Little is known about their behavior. We report 23 new cases.
Timothy Craig, Allen, Philip T, Cagle, Andrew M, Churg, Thomas V, Colby, Allen R, Gibbs, Samuel P, Hammar, Joseph M, Corson, Margaret M, Grimes, Nelson G, Ordonez, Victor, Roggli, William D, Travis, Mark R, Wick   +11 more
openaire   +2 more sources

Malignant Pleural Mesothelioma

Tumori Journal, 1978
A series of 12 cases of mesothelioma is presented, and the data in the literature is reviewed in an attempt to formulate a program of treatment for this malignant, fast-growing and rapidly fatal tumor.
M, Vaglini, F, Bozzetti, G, Viganotti
openaire   +2 more sources

Diffuse Malignant Mesothelioma

American Journal of Clinical Pathology, 1976
Thirteen cases of diffuse malignant mesothelioma, 12 pleural and one peritoneal, were examined and reviewed from the clinical and morphologic points of view. The most frequent symptom and sign were pain and effusion. Periods of survival varied, with one patient surviving 11 years despite morphologic features of the pleural tumor.
M, Klima, H J, Spjut, W D, Seybold
openaire   +2 more sources

Malignant Mesothelioma: Epidemiology

2014
Primary malignant neoplasms of the pleura and peritoneum originate from the mesothelial cells that line the respective cavities. The majority of these tumors are mesotheliomas. Mesothelioma is a relatively rare but very severe neoplasm, Exposure to asbestos (primarily on the workplace) is the main cause of mesothelioma.
openaire   +1 more source

Malignant pleural mesothelioma

Current Treatment Options in Oncology, 2000
Despite innumerable trials of surgery, radiotherapy, and countless chemotherapeutic drugs, it is unclear whether any intervention has had a significant impact on more than a few highly selected patients with malignant pleural mesothelioma. Because most patients die of respiratory failure from extensive disease progression in the thorax, treatment ...
openaire   +2 more sources

Malignant mesothelioma

Medical and Pediatric Oncology, 1985
Jules E. Harris, Kendrith Rowland, Elizabeth Brown, C. Frederick Kittle, Salitha Reddy   +4 more
openaire   +2 more sources

Immunotherapy approaches for malignant pleural mesothelioma

Nature Reviews Clinical Oncology, 2022
Dean A Fennell
exaly  

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

Lancet, The, 2021
Arnaud Scherpereel, Anna K Nowak, Nobukazu Fujimoto   +2 more
exaly